Advancing Precision in Microneedling with the 1NeedPro

Redefining microneedling through precision, versatility, and intelligent design, the 1NeedPro empowers clinicians to move beyond traditional collagen induction toward truly customised, multi-modality skin treatments.

What makes the 1NeedPro different from other microneedling devices currently available?
The 1NeedPro represents a significant step forward in microneedling technology by combining multiple treatment modalities within a single, medical-grade platform. Unlike conventional devices that focus solely on collagen induction, the 1NeedPro enables practitioners to tailor treatments through microneedling, micropricking, nanopeel, and uniquely, a single needle modality.
This versatility allows clinicians to move beyond generalised skin rejuvenation and adopt a more targeted, protocol-driven approach, adapting both depth and delivery depending on the indication and anatomical area.

Can you explain the science behind its multi-modality approach?
Each modality serves a distinct clinical purpose. Traditional microneedling stimulates fibroblast activity and collagen remodelling through controlled dermal injury. Micropricking operates more superficially, enhancing transepidermal delivery of actives, including exosomes and chemical peels, without significant downtime.
Nanopeel introduces a controlled form of epidermal resurfacing, supporting uniform exfoliation and optimised topical efficacy. By integrating these approaches, the device allows practitioners to layer treatments intelligently, improving both outcomes and patient experience.

The Single Needle feature is often highlighted as unique, why is this
significant?
The Single Needle cartridge is a key point of differentiation and addresses a gap in current microneedling technology. Most devices rely on multi-needle arrays, which are effective for treating larger surface areas but lack precision when addressing individual lesions or highly localised concerns. With a single needle, practitioners can perform controlled, point-specific treatment, making it particularly valuable for:

• Isolated acne lesions.

• Persistent inflammatory spots.

• Small or difficult-to-reach scar tissue.

• Localised textural irregularities.

From a clinical perspective, this enables a more conservative and precise intervention, reducing unnecessary trauma to surrounding
tissue while maintaining efficacy. It also opens the door to more advanced, combination-led protocols where both global and focal treatment strategies can be applied within the same session.

How does the device address safety and consistency in treatment delivery?

The 1NeedPro incorporates several engineering features designed to support clinical safety and reproducibility. The PD/DS (Precise Depth
System) allows for consistent needle penetration, which is critical when working across varying skin thicknesses and treatment indications.
In addition, the patented NOFLOW® system is designed to minimise backflow and reduce the risk of cross-contamination, supporting high standards of hygiene in clinical practice.

Before 1 treatment

After 1 treatment

These features collectively enable practitioners to deliver treatments with greater confidence, control, and predictability. What does this mean for practitioners in terms of clinical outcomes and business growth?
From a clinical standpoint, the ability to combine multiple modalities, including precise single-needle interventions, supports more customised treatment protocols and improved patient outcomes.

From a business perspective, this versatility allows clinics to expand their treatment offering without investing in multiple devices. It also enhances treatment efficiency, patient satisfaction, and retail opportunities, particularly when integrating post-procedure skincare.
Ultimately, the 1NeedPro aligns with the evolving direction of aesthetic medicine, moving towards precision-based, evidence-led, and patient-specific treatment strategies.

What feedback have you received from clinicians using the 1NeedPro?
Early clinical feedback has been extremely positive, particularly around the device’s precision, versatility, and consistency of results. Practitioners have highlighted the ability to combine multiple modalities within a single treatment, alongside the enhanced control offered by the device’s engineering.

The Single Needle capability has been a standout feature, enabling clinicians to treat individual lesions and localised concerns with a level of precision not typically achievable with traditional multi-needle
systems.

As noted by Dr. Anoob Pakkar-Hull: “In my hands, 1NeedPro stands out for one reason. Its single-needle, no-flow design delivers a level of precision and predictability that elevates my outcomes.”
Similarly, Dr. Paris Acharya comments: “The 1NEED Pro has quickly become an indispensable part of my clinical toolkit. I’ve been impressed with the consistency of results, patient comfort, and the noticeable improvement in overall skin quality.”

This feedback reinforces the 1NeedPro as a precision-led, clinically driven platform, supporting both advanced protocols and improved patient outcomes.